Thursday, October 10, 2019

Contact Lenses Market Share, Scope, Growth Opportunities Analysis and Forecast 2026

New York, 10, Oct 2019: According to a new study published by Polaris Market Research the global contact lenses market is anticipated to reach USD 18.9 billion by 2026. Once of the key factor driving the contact lenses market is to enhance aesthetic appearance by using them as fashion accessory particularly, by the youth population. Also, constant development in technology of product materials and given a boost to colored or decorative contact lenses, which is further anticipated to influence the demand. Moreover, the rising incidences of visual imparities such as myopia, presbyopia, hyperopia and astigmatism is propelling the market growth. The World Health Organization, in 2015, estimated that approximately 1.9 billion people across the globe have been affected by myopia and the number is anticipated to be more than 2 billion by 2020. Thus, the demand for contact lenses during the forecast period will experience a growth.

The contact lenses manufacturers and vendors are appealed by the high profit margins offered by the contact lenses thus, boosting its manufacturing as well as enhancing the network of distribution. Also, advancements in technology in form of material will provide new opportunities to the manufacturers with time. By type segment, the Rigid Gas Permeable (RGP) Lenses was valued over USD 800 million in 2017 owing to factors including, sharp vision, high oxygen permeability, cost-effectiveness in the long run, and durability.
The contact lenses market by usage type is segmented into Corrective, Therapeutic, Cosmetic, Prosthetic, and Lifestyle-oriented. The corrective lenses usage segment is currently growing at a CAGR of more than 6.2%. The demand is attributed to its various applications. Whereas, cosmetic lenses segment is expected to witness high growth during the forecast period. On the basis of design, the hybrid lens segment is anticipated to experience a noteworthy growth as it is a combination of both soft lenses and rigid gas permeable lenses. Thus, it provides comfort of soft lenses coupled with the visual clarity offered by rigid gas permeable lenses. The growth of hybrid lenses segment is expected to propel with the increased demand from people with keratoconus and astigmatism conditions.

The North America market holds the largest share owing to presence of better eye care treatment facilities as increasing elderly population. Although, the Asia Pacific market is expected to bolster with a high CAGR attributed to the increased awareness regarding contact lenses among the population as well as their increasing ability for healthcare spending.
The key strategies adopted by the market players include long-term partnerships among the other players in supply chain particularly, distributors and suppliers with an aim to increase their geographical footprint. For instance, in 2016, Vision Direct Group Ltd. was acquired by Essilor International S.A. for the enhancement of its online retailing business presence. Major industry players include Alcon Laboratories, Inc., Abbott Medical Optics, Inc., Bausch + Lomb, Incorporated, Carl Zeiss AG, CooperVision, Inc., Contamac U.S., Inc., Hoya Corporation, Essilor International S.A., Medennium and Johnson & Johnson Vision Care, Inc. among others.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Wednesday, October 9, 2019

CBD Oil Market Reviewed for 2019 with Industry Outlook to 2026

New York, 09, Oct 2019The global CBD Oil market size is expected to reach USD 3,095.3 million by 2026 according to a new study by Polaris Market Research. The report “CBD Oil Market Share, Size, Trends, Industry Analysis Report By Product (Hemp Based and Marijuana Based), By Application (Pharmaceuticals, Food & Beverages, Cosmetics and Others); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online, Others); By Regions, Segments & Forecast, 2019 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.


Flexibility of CBD oil thus resulting in a wide variety of applications, health benefits such as ability to boost cognitive abilities, anti-inflammatory properties, among others, and information outburst through a variety of platforms including social media are benefitting the CBD oil market demand. Development of novel products such as CBD oil infused honey and aggressive marketing strategies adopted to promote the same is also expected to benefit the overall market growth.

Polaris Market research has segmented the CBD oil market report on the basis of product, application, distribution channel and region

In the past, CBD related research was restricted to the treatment of severe diseases such as cancer and epilepsy and this put limitations on the usage in other avenues such as cosmetics. However, with multinationals taking interest in the product, the research horizon widened and properties such as anti-inflammatory were discovered which led to the usage of the oil not just by health provider brands but by wellness brands as well. This widened usage coupled with the rising preference for preventive healthcare has fueled CBD oil market growth across the globe.

The key players in the market for CBD oil include ENDOCA, Isodiol, Medical Marijuana, Cannoid., Canopy Growth Corporation, Elixinol Group, Folium Biosciences, Diamond CBD, NuLeaf Naturals, PharmaHemp, Aphria Inc. and Gaia Botanicals among others. Development of distribution channels, novel product development and aggressive marketing campaigning are some of the success factors in the industry.

To customize the study according to your specific requirements please click : https://www.polarismarketresearch.com/industry-analysis/cbd-oil-market/request-for-customization
  
Rise in millennial population is also benefitting the market demand. Bath soaps, lip gloss, face creams, lotions, serums, medicines for curing muscle pains are some of the products that are appealing to this segment of customers. Furthermore, companies are adopting SEO centric strategies to create online awareness regarding CBD oil products among these millennials. This category of customers is looking to boost their cognitive ability or health functions through usage of novel ways and CBD oil infused products fits this demand perfectly.

North America emerged as the largest market for CBD oil in 2018 and is expected to maintain its dominance over the forecast period. Strong presence of companies in the US, high awareness regarding CBD oil usage, availability of a wide variety of products as well as efficient distribution channels leading to easy availability are some of the factors benefitting the regional market demand. Acquisition of companies having good brand recall and brand awareness by multinationals is a key market scenario in the region.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world

Contact us






Thursday, October 3, 2019

Gout Therapeutics Market Size, Production, Revenue, Growth & Analysis by Regions


New York City, 03 Oct 2019 : The global gout therapeutics market is predicted to grow at a CAGR of 15.2% from 2019 to 2026 to reach USD 9,815.6 million by 2026, according to a new market report published by Polaris Market Research. The report Gout Therapeutics Market Size, Share, Trends & Analysis Report, By Drug Class (Urate-Lowering Agents, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Colchicine); By Disease Condition (Chronic Gout, Acute Gout); By Region, Segment Forecast, 2019 – 2026 provides in depth analysis of the current and future market trends.

The incidence of gout has witnessed continual growth over the past years. It is majorly caused by uncontrolled metabolic disorder and high level of uric acid in the body. U.S. region is observed to have a high prevalence of gout owing to lifestyle issues such as high alcohol intake, obesity, and smoking resulting in the inflammatory disorder. 
Attributed to these factors along with the adoption of innovative treatments and increased understanding about arthritic conditions, the market in North America region is observed to be the dominant market across all regions during 2018. While, the Asia Pacific regional market is expected to witness highest growth rate owing to rising healthcare expenditure among the developing economies and significant investments by key players in this region.
As per the severity of gout condition recommendations of medications and therapies are made to the respective patients. Multiple pharmaceutical companies have consistently increased the R&D investments to come up with further effective medications. The market for therapeutics of acute and chronic gout has witnessed significant growth over the past years and is expected to continue its growth trend. Although both segments are anticipated to grow, chronic gout segment presently holds major market share.  
NSAIDs, corticosteroids are among the approved drugs for treating gout condition and are available for purchase over the counter. These drugs are observed to be greatly effective in treating mild gout conditions and are expected to have significant impact on driving the growth in global gout therapeutics market. Moreover, rising preference for combination therapies due to benefits such as speeding up the treatment process, reduction in side effects is also another factor enhancing the market growth.
Some of the key players in this market are AstraZeneca, Horizon Pharma plc, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Teijin Pharma Limited, Regeneron Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., JW Pharmaceutical, Selecta Biosciences, Inc., and Grunenthal Group. Companies are also increasingly having their focus on regenerative medicines which is further expected to contribute in the growth of gout therapeutics market. 
 About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world
Contact us : Web: http://www.polarismarketresearch.com